Truist Securities Maintains Hold on Amgen, Raises Price Target to $380
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice TargetHot
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $362 to $380.
Truist Securities analyst Gregory Renza maintains Amgen (NASDAQ:AMGN) with a Hold and raises the price target from $362 to $380.